Health Products

Teva-Galantamine ER (2013-12-12)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
G82004
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Teva-Galantamine ER Extended Release CapsuleDIN 0237797724 mg

Introduction

Recalled Products

Teva-Galantamine ER

Reason

Potential for product to not meet its stability dissolution specifications.

Depth of distribution

Retailers in Alberta, British Columbia, Saskatchewan, Manitoba, Ontario, Quebec, Newfoundland, New Brunswick, Nova Scotia.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime